News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Targacept, Inc. (TRGT) to Present at the 15th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference



2/4/2013 7:01:23 AM

Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeutics (TM), today announced that Dr. Stephen A. Hill, President and Chief Executive Officer, is scheduled to present at the 15th Annual BIO CEO & Investor Conference at The Waldorf Astoria New York in New York City on Monday, February 11, 2013 at 1:00 p.m. Eastern Time.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES